×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
LS51 Next-Generation Digital Healthcare Considering Pre-Symptomatic State, Prevention, and Well-Being (Part 2)
Session Chair(s)
Takashi Moriya, PhD, MBA
Director, VEO Vaccines Value Evidence and Outcomes, Japan MA
GlaxoSmithKline K.K., Japan
Speaker(s)
Takeru Hiki
Welby Inc, Japan
CEO
Hiroyuki Idone
Novo Nordisk Pharma Ltd., Japan
Digital Health Program Lead